Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
13 November 2023 |
Main ID: |
NCT02267252 |
Date of registration:
|
08/10/2014 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Effects of Male-specific Antibodies on Sex Ratio
|
Scientific title:
|
|
Date of first enrolment:
|
September 2014 |
Target sample size:
|
30 |
Recruitment status: |
Recruiting |
URL:
|
https://clinicaltrials.gov/ct2/show/NCT02267252 |
Study type:
|
Observational |
Study design:
|
|
Phase:
|
|
|
Countries of recruitment
|
Denmark
| | | | | | | |
Contacts
|
Name:
|
Jens Fedder, MD, PhD |
Address:
|
|
Telephone:
|
+45 26820368 |
Email:
|
fedder@dadlnet.dk |
Affiliation:
|
|
|
Name:
|
Jens Fedder, Professor |
Address:
|
|
Telephone:
|
+45 268 20 368 |
Email:
|
fedder@dadlnet.dk |
Affiliation:
|
|
| |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Vasectomized men
Exclusion Criteria:
- Men who do not understand the study information
Age minimum:
25 Years
Age maximum:
N/A
Gender:
Male
|
Health Condition(s) or Problem(s) studied
|
Sex Ratio
|
Sperm Antibodies
|
Intervention(s)
|
Other: Antibody-sperm binding
|
Primary Outcome(s)
|
Y/X sperm ratio after exposure to sperm-specific antibodies
[Time Frame: Up to 28 months]
|
Secondary ID(s)
|
Lab.Reprod.Biol.- Odense.01
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|